Catalyst Wire Dossier Catalyst Wire Dossier

WYNZORA

calcipotriene and betamethasone dipropionate · MC2 Therapeutics Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WYNZORA, covering 2020-07-20 to 2020-07-20. Get the full timeline:

Most recent: FDA Approved: WYNZORA — Original Application (MC2 Therapeutics Ltd)

See pricing